So-ching Brazer, Ph.D., RAC
San Francisco Bay Area
685 followers
500+ connections
San Francisco Bay Area
685 followers
500+ connections
About
Accomplished Regulatory professional with 15 years of experience in developing regulatory…
Activity
-
Gene therapy landscape Pulled together 42 companies and charted the preclinical and clinical assets of each, segmented by approach and vector Some…
Gene therapy landscape Pulled together 42 companies and charted the preclinical and clinical assets of each, segmented by approach and vector Some…
Liked by So-ching Brazer, Ph.D., RAC
-
Adicet Bio, Inc is pleased to welcome Dr. Lloyd Klickstein to our Board of Directors! Dr. Klickstein’s expertise in rheumatology and immunology…
Adicet Bio, Inc is pleased to welcome Dr. Lloyd Klickstein to our Board of Directors! Dr. Klickstein’s expertise in rheumatology and immunology…
Liked by So-ching Brazer, Ph.D., RAC
-
"Driving fundamental change isn’t an easy road, but it’s a worthy one. That's why I decided to write this guide—to share my own experiences, lessons…
"Driving fundamental change isn’t an easy road, but it’s a worthy one. That's why I decided to write this guide—to share my own experiences, lessons…
Liked by So-ching Brazer, Ph.D., RAC
Experience
Education
Licenses & Certifications
More activity by So-ching
-
We’re pleased for Adicet’s Head of Clinical Operations, Ekatherina Goryachikov to share best practices for designing and running a CAR T cell therapy…
We’re pleased for Adicet’s Head of Clinical Operations, Ekatherina Goryachikov to share best practices for designing and running a CAR T cell therapy…
Liked by So-ching Brazer, Ph.D., RAC
-
We’re honored for our Chief Medical Officer, Dr. Francesco Galimi, MD PhD and our Head of Clinical Operations, Ekatherina Goryachikov to have…
We’re honored for our Chief Medical Officer, Dr. Francesco Galimi, MD PhD and our Head of Clinical Operations, Ekatherina Goryachikov to have…
Liked by So-ching Brazer, Ph.D., RAC
-
Dr. Francesco Galimi, MD PhD, Adicet Chief Medical Officer, leads several sessions this week at the Gamma Delta T Cell Therapies Summit! Along with…
Dr. Francesco Galimi, MD PhD, Adicet Chief Medical Officer, leads several sessions this week at the Gamma Delta T Cell Therapies Summit! Along with…
Liked by So-ching Brazer, Ph.D., RAC
-
I’m happy to share that I’ve been promoted to Senior Research Associate at Adicet Bio, Inc!
I’m happy to share that I’ve been promoted to Senior Research Associate at Adicet Bio, Inc!
Liked by So-ching Brazer, Ph.D., RAC
-
Iâm excited to join the gAlumni Network online platform - created for friends and former colleagues to access the untapped power, value and impact…
Iâm excited to join the gAlumni Network online platform - created for friends and former colleagues to access the untapped power, value and impact…
Liked by So-ching Brazer, Ph.D., RAC
-
I am excited to attend this event and look forward to seeing you there!
I am excited to attend this event and look forward to seeing you there!
Liked by So-ching Brazer, Ph.D., RAC
-
Eli Lilly and Company offers employees two extra weeks off every year for our summer and winter shutdown, in addition to our generous time off…
Eli Lilly and Company offers employees two extra weeks off every year for our summer and winter shutdown, in addition to our generous time off…
Liked by So-ching Brazer, Ph.D., RAC
-
The importance of a robust potency assay strategy cannot be underestimated, as outlined in recent FDA Guidance. We are delighted to announce…
The importance of a robust potency assay strategy cannot be underestimated, as outlined in recent FDA Guidance. We are delighted to announce…
Liked by So-ching Brazer, Ph.D., RAC
-
We are growing again! We extend our warmest Opus welcome to our newest team member Rebecca Lalani. Thank you for being part of our team! 👏
We are growing again! We extend our warmest Opus welcome to our newest team member Rebecca Lalani. Thank you for being part of our team! 👏
Liked by So-ching Brazer, Ph.D., RAC
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More